IXHL — Incannex Healthcare Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1873875 ·
Australia
Last close
$3.36
Market Cap
$40.20M
52W High
$6.46
52W Low
$2.49
ADV30
375,295
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -3,966,000 | -3,883,000 | 80,283,000 | 74,450,000 | 5,049,000 |
| Dec 2025 | 0 | — | -6,513,000 | -6,521,000 | 75,006,000 | 68,900,000 | 1,600,000 |
| Sep 2025 | 0 | — | -6,405,000 | -6,407,000 | 78,720,000 | 73,280,000 | 1,712,000 |
| Mar 2025 | 0 | — | -4,582,000 | -3,968,000 | 16,197,000 | 6,711,000 | 8,794,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-22,571,000
Investing CF
$-54,000
Financing CF
$79,898,000
CapEx
$-6,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-17.10
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-170,484,000
Inventory
—
Receivables
$5,299,000
ST Investments
—
EBIT TTM
$-22,485,000
Pretax Income TTM
$-22,790,000
Interest Exp TTM
$303,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
$-24,695,000
Free Cash Flow
$-8,271,875
Enterprise Value
$-32,220,770
Total Cash
$74,450,000
Total Debt
$114,000
Shares Out
11,964,554
Trailing EPS
$-16.62
Book Value
$5.50
ROE
-117.2%
ROA
-32.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | — | — | — | — | — | — | — |
| Jun 2024 | 12,000 | -18,607,000 | -18,459,000 | 17,047,000 | 5,830,000 | — | -15,845,000 |
| Jun 2023 | 0 | -13,638,000 | -48,811,000 | 23,783,000 | 2,958,000 | — | -10,749,000 |
| Jun 2022 | 0 | -10,164,241 | -10,252,538 | 26,057,735 | 1,383,064 | — | -8,810,311 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.96
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KALA | KALA BIO, Inc. | $40.34M | $2.17 | — |
| ZYBT | Zhengye Biotechnology Holding Ltd | $40.75M | $0.86 | — |
| MIRA | MIRA PHARMACEUTICALS, INC. | $40.93M | $0.97 | — |
| RNXT | RenovoRx, Inc. | $41.30M | $0.92 | — |
| TLPH | TALPHERA, INC. | $41.52M | $0.80 | — |
News headlines (Yahoo Finance, 1h cache)
Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea
2026-05-14 14:35 · Yahoo
Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development
2026-05-12 12:00 · Yahoo
Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness
2026-04-22 12:00 · Yahoo
Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position
2026-03-27 12:00 · Yahoo
Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research
2026-03-25 12:00 · Yahoo
Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development
2026-03-18 12:00 · Yahoo
Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement
2026-03-17 12:00 · Yahoo
Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2026-03-12 12:05 · Yahoo
Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes
2026-03-12 12:00 · Yahoo
Incannex Healthcare Inc. (IXHL) Implements 1-for-30 Reverse Split Effective February 26
2026-03-03 20:24 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.